Beijing Med-Pharm Acquires Chinese OTC Drug Manufacturer Sunstone
This article was originally published in The Tan Sheet
Executive Summary
SHANGHAI - Beijing Med-Pharm's acquisition of Chinese OTC drug manufacturer Sunstone Pharmaceutical Co. will help it capitalize on the growing Chinese retail pharmacy space, BMP Chief Financial Officer Fred Powell said in an interview with PharmAsia News
You may also be interested in...
Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.
Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.
Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.